High-Throughput DNA Plasmid Multiplexing and Transfection Using Acoustic Nanodispensing Technology
August 8th, 2019
8.4K views
This protocol describes high-throughput plasmid transfection of mammalian cells in a 384-well plate using acoustic droplet ejection technology. The time-consuming, error-prone DNA dispensing and multiplexing, but also the transfection reagent dispensing, are software-driven and performed by a nanodispenser device. The cells are then seeded in these prefilled wells.
Overview
This protocol describes a user-friendly, high-throughput method for plasmid transfection of mammalian cells using acoustic droplet ejection technology. It allows for the transfection of cells under 384 independent conditions, making it suitable for both beginners and experienced researchers.
Key Study Components
Area of Science
- Cell Biology
- Transfection Techniques
- High-Throughput Screening
Background
- Traditional DNA dispensing methods can be time-consuming and error-prone.
- Acoustic droplet ejection technology streamlines the transfection process.
- This method reduces reagent costs due to the nano volume required.
- It is designed to be accessible for beginners in the field.
Purpose of Study
- To develop a high-throughput transfection protocol that is easy to use.
- To optimize transfection parameters for various cell types.
- To facilitate efficient DNA dispensing and transfection reagent handling.
Methods Used
- Utilization of a NanoDispenser for precise DNA and reagent dispensing.
- Adjustment of flow rates to minimize cell damage during dispensing.
- Testing varying amounts of DNA and transfection reagents.
- Seeding cells in a 384-well plate format.
Main Results
- The protocol enables successful transfection across multiple conditions.
- Low-cost reagents are effective due to the nano volume used.
- Adjusting dispensing parameters improves cell viability.
- Beginners can achieve reliable results with this method.
Conclusions
- This high-throughput transfection method is efficient and user-friendly.
- It provides a viable option for researchers working with mammalian cells.
- Future studies can build on this protocol to explore various transfection conditions.
Frequently Asked Questions
What is the main advantage of this transfection method?
The main advantage is its high-throughput capability, allowing for multiple conditions to be tested simultaneously.
Is this method suitable for beginners?
Yes, the protocol is designed to be user-friendly, making it accessible for researchers new to transfection techniques.
What equipment is needed for this protocol?
A NanoDispenser and a peristaltic liquid handler are required for dispensing reagents and cell suspensions.
How does the method reduce costs?
The method uses nano volumes of reagents, significantly lowering the amount of material needed for transfection.
Can this method be used for different cell types?
Yes, the protocol allows for optimization of transfection parameters for various mammalian cell types.
What is the importance of adjusting flow rates?
Adjusting flow rates helps to minimize shear stress and potential damage to the cells during dispensing.
Executive Industry Relevance
High-throughput plasmid transfection using acoustic nanodispensing addresses the bottleneck of low-throughput, error-prone transfection workflows in early discovery. By enabling precise, multiplexed delivery of up to four plasmids per well in a 384-well format, the method supports rapid parameter optimization and cotransfection efficiency near 100%, directly accelerating target validation and mechanistic de-risking in plasmid-based screening campaigns.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of therapeutic hypotheses through multiplexed plasmid delivery for pathway clarification and functional target validation.
- Operational Value: Supports biological de-risking by allowing systematic testing of DNA amounts, transfection reagent, and cell density across 384 conditions to identify optimal transfection settings.
- Predictive Confidence: Facilitates portfolio triage by generating reproducible, quantitative transfection efficiency data to prioritize constructs for downstream applications such as ORF expression or CRISPR-Cas9 gene function validation.
Screening & Assay Development
- Assay Readiness: Prepares validated biological systems for downstream workflows by ensuring consistent plasmid and transfection reagent dispensing via user-friendly spreadsheet macro and tablet-based pipetting guide.
- Reproducibility & Scalability: Enables assay standardization through precise nanovolume control (e.g., 500 nL transfection reagent, 100 ng/µL DNA) and automated picklist generation, supporting reliable compound or genetic screening in nonpooled formats.
- Platform Reuse: The method’s compatibility with 384-well plate formats allows transposition to higher-scale manual approaches and reuse across diverse cell types and plasmid libraries (up to 1,536 plasmids).
Translational & Preclinical Research
- Translational Continuity: Supports seamless transition from discovery to preclinical validation by enabling consistent, high-efficiency transfection (up to 90%) in mammalian cells, critical for modeling gene function and protein expression in disease-relevant systems.
- Mechanistic De-risking: Reduces ambiguity in cotransfection experiments by achieving nearly 100% cotransfection efficiency, ensuring that observed phenotypes reflect combined plasmid effects rather than variable delivery.
- Risk-Adjusted Advancement: Provides quantitative, threshold-based outputs (e.g., transfection efficiency, cotransfection rates) that inform go/no-go decisions in lead identification pipelines.
Pipeline & Workflow Integration
The method integrates into the discovery continuum from early target validation through lead identification, enabling high-throughput screening of genetic constructs in a format compatible with downstream analytics and preclinical follow-up.
- Discovery Biology: Supports hypothesis testing and pathway clarification by enabling multiplexed plasmid delivery and precise titration of genetic variables across hundreds of conditions.
- Screening: Delivers assay readiness through standardized, reproducible dispensing of DNA and transfection reagent, ensuring consistent transfection efficiency for reliable compound or genetic screening.
- Analytics: Generates quantitative readouts (transfection efficiency, cotransfection rates) via fluorescence-based analysis, enabling statistical comparison of conditions and construct performance.
- Translational Research: Connects discovery to preclinical work by providing a scalable, reliable transfection platform suitable for validating gene function and protein expression in disease models.
- Enterprise Reuse: Positions the method as a reusable capability across projects, reducing redundancy in transfection protocol development and enabling platform-wide standardization.
Operational & Enterprise Impact
- Scientific Value: Predictive confidence in target validation, reduction of mechanistic ambiguity in cotransfection, and enhanced functional genomics screening.
- Operational Value: Standardization, reproducibility, and scalability of transfection workflows through nanovolume precision and spreadsheet-driven automation.
- Strategic Value: Improved go/no-go decisions, capital efficiency via reduced reagent consumption, and decreased late-stage biological risk from better early-phase de-risking.
- Portfolio Impact: Enables risk-adjusted prioritization of genetic constructs based on transfection performance and cotransfection fidelity.
Implementation Considerations
- Requires expertise in cell culture, transfection principles, and liquid handling instrumentation.
- Dependent on NanoDispenser hardware, peristaltic liquid handler, and compatible software (spreadsheet macro, tablet application).
- Necessitates cross-team standardization of plate formats, reagent concentrations, and dispensing parameters for reproducible results.
- Involves adaptation considerations when transferring protocols across different cell types, plasmid libraries, or endpoint assays (e.g., fluorescence, luminescence).
- Practical limitations include the need for manual source plate preparation (dilution, dispensing) and dependency on accurate calibration of dispensing hardware to avoid volume inaccuracies.
Biopharma FAQs
Why does null hypothesis testing matter for target validation in multiplexed transfection?
Null hypothesis testing enables rigorous comparison of transfection efficiency across varying DNA amounts, reagent concentrations, and cell densities, ensuring observed effects are statistically significant and not due to random variation in delivery efficiency.
How does independent variable isolation fit the discovery pipeline in high-throughput transfection?
Isolating variables such as DNA amount or transfection reagent concentration allows researchers to systematically identify optimal conditions for each construct, directly supporting lead identification by linking genetic design to functional output.
What quantitative dependent variable measurements enable lead identification in plasmid screening?
Fluorescence-based measurement of transfection efficiency and cotransfection rates provides quantitative, normalized readouts that allow ranking of plasmids by performance, enabling data-driven selection for downstream validation.
Why do replication requirements matter for cross-functional collaboration in transfection workflows?
Replication ensures consistent transfection efficiency across plates and experiments, which is essential for reliable data sharing between discovery, screening, and preclinical teams, reducing variability in interpretive conclusions.
What statistical analysis capabilities are required before implementing this transfection method in screening campaigns?
The method requires basic statistical comparison of transfection efficiency across conditions (e.g., t-tests, ANOVA) to determine significant differences and establish robust thresholds for hit selection in genetic screens.
Chapters in this video
0:04
Title
0:47
Preparation of the Peristaltic Liquid Handler Programs
1:53
Experimental Design and Generation of the Picklists to Drive the Acoustic Droplet Ejection (ADE)-Based Dispenses
3:34
DNA Source Plate Preparation Using the 384-well Pipetting Guide Application and Survey Performance to Control the Manually Dispensed Volumes
6:18
Peristaltic Liquid Handler-Based 1 μL Diluent Dispensation in the Destination Plate
7:03
ADE-driven DNA Dispensing into the Destination Plate and ADE-driven Transfection Reagent Dispensing
9:54
Peristaltic Liquid Handler-Based Cell Dispensation
10:51
Results: Defining the Key Parameters to Reach Highly Efficient and High Thoughput Cells (Co-) Transfections
12:26
Conclusion
